Pfizer Inc.
(NYSE: PFE)

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare. The Company�s diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Its Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. Primary Care operating segment includes revenues from human prescription pharmaceutical products primarily prescribed by primary-care physicians. In November 2012, the Company acquired NextWave Pharmaceuticals, Inc. On November 30, 2012, the Company completed the sale of its Nutrition business.

25.575 -

-0.525 (-2.01%)
Range 25.510 - 25.685   (0.69%)
Open 25.590
Previous Close 26.100
Bid Price 25.570
Bid Volume 1,338
Ask Price 25.580
Ask Volume 1,216
Volume 9,987,474
Value 151,483,917
Remark -
Delayed prices. Updated at 23 Jan 2026 23:25.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Dividend

Ex-Date 23 January 2026
Record Date 23 January 2026
Payable Date 23 January 2026
DIVIDEND : USD 0.43. Amount: USD0.43
View All Events

About Pfizer

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare. The Company�s diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Its Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. Primary Care operating segment includes revenues from human prescription pharmaceutical products primarily prescribed by primary-care physicians. In November 2012, the Company acquired NextWave Pharmaceuticals, Inc. On November 30, 2012, the Company completed the sale of its Nutrition business.

Loading Chart...

Please login to view stock data and analysis